Clinical trials in India Uncertainty lingers
As the Indian clinical research industry strives to adhere to the numerous changes announced last year, the delay in clearing up…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Clinical trials: Perception vs reality
As regulators and industry hammer out practical implementation strategies of India's evolving clinical trial regulations, both…
Harnessing Asia’s clinical trial potential
Lisa Marie Saldanha, Director, Head of Site Identification Services Asia, Quintiles and Dr Karen Wai, Senior Director, Head, Site…
India, China and other emerging markets key prospects for interventional cardiac device…
Report says that manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand
Suven Life Sciences secures two product patents for their NCEs in the US
Will help in the treatment of disorders associated with neurodegenerative diseases
IDRI and Jubilant Chemsys extend research for TB drug discovery
The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis
US FDA approves Piramal Imaging’s Neuraceq
Will help in PET imaging of beta-amyloid neuritic plaques in the brain
Urgent action needed to prevent unregulated sale of TB drugs in India: MSF
Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India
Novartis bags approval of Xolair
Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU
Glenmark receives $4 million through Swiss subsidiary
Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…